Abstract:Objective To explore the improvement of noninvasive electrostatic field stimulation (NEFS) on neurocognitive impairment mice induced by lipopolysaccharide (LPS). Methods Forty-eight female C57 mice aged 3 months were divided into the CTL group, the NaCl+NEFS group, the LPS+SHAM group and the LPS+NEFS group, with 12 mice in each group. Both the LPS+NEFS group and the LPS+SHAM group were injected with 2 mg/kg LPS intraperitoneally to establish the mouse model of neurocognitive impairment, and after the model was constructed, they were treated with NEFS for 4 d, during which the LPS+NEFS group received an electrostatic field of 160 kV/m for 30 min/d while the LPS+SHAM group were only stimulated by an electrostatic field of 0 kV/m for 3 s/d. The NaCl+NEFS group was injected with the same amount of 0.9% normal saline instead of LPS and stimulated by electrostatic field (160 kV/m); The CTL group was a no-treatment group. After NEFS, the cognitive ability of mice was observed by T maze experiment (T-maze) and the new object recognition (NOR) experiment. Immunohistochemical method was used to detect the number of hippocampal neurons in mice, and immunofluorescence method was used to detect the changes of hippocampal astrocytes. Results Compared with the results of behavioral experiment and morphological observation of the CTL group, the learning and memory abilities of the LPS+SHAM group in T-maze and NOR was significantly weakened (P < 0.05), and the number of neurons in hippocampus decreased significantly while the number of activated astrocytes increased significantly (P < 0.05). Furthermore, compared with the LPS+SHAM group, the learning and memory abilities of the LPS+NEFS group in T-maze and NOR was significantly improved (P < 0.05), and the number of neurons in hippocampus was also significantly increased (P < 0.05), and the proliferation of astrocytes was significantly inhibited (P < 0.05). Conclusion Intraperitoneal injection of 2 mg/kg LPS can establish neurocognitive impairment model, and NEFS has protective effect on LPS-induced neurocognitive impairment in mice. [Key words] electric stimulation therapy , neurocognitive impairment , neuroprotection ,

Model of neuroinflammation associated with cognitive dysfunction established by intraperitoneal injection of LPS

Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice

The Immune System Drives Synapse Loss During Lipopolysaccharide-Induced Learning and Memory Impairment in Mice

Integrated Proteomic and Phosphoproteomic Analysis of the Hippocampus in a Mouse Model of Early Life Inflammation

Complement C1q drives microglia-dependent synaptic loss and cognitive impairments in a mouse model of lipopolysaccharide-induced neuroinflammation

Metabolomic, Lipidomic and Proteomic Characterisation of Lipopolysaccharide-induced Inflammation Mouse Model

Short-term memory impairment following recovery from systemic inflammation induced by lipopolysaccharide in mice

Identification and analysis correlation between hub genes and immune cell infiltration related to LPS-induced cognitive impairment

Locomotor and gait changes in the LPS model of neuroinflammation are correlated with inflammatory cytokines in blood and brain

Resveratrol Attenuates Subacute Systemic Inflammation-Induced Spatial Memory Impairment Via Inhibition of Astrocyte Activation and Enhancement of Synaptophysin Expression in the Hippocampus.

Lipopolysaccharide induces paired immunoglobulin-like receptor B (PirB) expression, synaptic alteration, and learning-memory deficit in rats

Systemic Inflammation Impairs Mood Function by Disrupting the Resting-State Functional Network in a Rat Animal Model Induced by Lipopolysaccharide Challenge.

Disinhibition of hippocampal parvalbumin interneurons on pyramidal neurons participates in LPS-induced cognitive dysfunction

NLRP3 inflammasome of microglia promotes A1 astrocyte transformation, neo-neuron decline and cognition impairment in endotoxemia.

Trained Innate Immunity by Repeated Low-Dose Lipopolysaccharide Injections Displays Long-Term Neuroprotective Effects

A Pilot Study to Investigate Peripheral Low-Level Chronic LPS Injection as a Model of Neutrophil Activation in the Periphery and Brain in Mice

Effects of immune activation on the retrieval of spatial memory

Neuroinflammatory transcriptional signatures in the entorhinal cortex based on lipopolysaccharide-induced depression model in mice

Improvement of Noninvasive Electrostatic Field Stimulation on Lipopolysaccharide-Induced Neurocognitive Impairment Mice

Reduced inhibition underlies early life LPS exposure induced-cognitive impairment: Prevention by environmental enrichment

Neural Network Disturbance in the Medial Prefrontal Cortex Might Contribute to Cognitive Impairments Induced by Neuroinflammation